Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021

MLA

Teresa Zuppini, et al. “Comparison of Medium-Term Adverse Reactions Induced by the First and Second Dose of MRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) Vaccine: A Post-Marketing Italian Study Conducted between 1 January and 28 February 2021.” European Journal of Hospital Pharmacy : Science and Practice, June 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6f14fbcefe5073bf0d386ca45646fe2c&authtype=sso&custid=ns315887.

APA

Teresa Zuppini, Nicola Realdon, Andrea Ossato, Carlotta Trabucchi, Francesca Marchesini, & Roberto Tessari. (2021). Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021. European Journal of Hospital Pharmacy : Science and Practice.

Chicago

Teresa Zuppini, Nicola Realdon, Andrea Ossato, Carlotta Trabucchi, Francesca Marchesini, and Roberto Tessari. 2021. “Comparison of Medium-Term Adverse Reactions Induced by the First and Second Dose of MRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) Vaccine: A Post-Marketing Italian Study Conducted between 1 January and 28 February 2021.” European Journal of Hospital Pharmacy : Science and Practice, June. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....6f14fbcefe5073bf0d386ca45646fe2c&authtype=sso&custid=ns315887.